Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2018 Filed Apr 3, 2018 21:26 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
Tax withholdingCommon Stock | 2,162 | $62.21 | $134,498.02 |
DisclosureSEC source: 0001127602-18-013817 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,086 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:29 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 35,030 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-18-013821 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,030 Underlying: Common Stock · 35,030 shares Expires 2025-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:29 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 594 | $62.21 | $36,952.74 |
DisclosureSEC source: 0001127602-18-013821 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,850.9749 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:38 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantStock Option · Derivative | 87,575 | $62.21 Strike: $62.21 | $5,448,040.75 |
DisclosureSEC source: 0001127602-18-013834 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,575 Underlying: Common Stock · 87,575 shares Expires 2025-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:38 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 4,047 | $62.21 | $251,763.87 |
DisclosureSEC source: 0001127602-18-013834 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,723.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:40 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 275 | $67.73 | $18,625.75 |
DisclosureSEC source: 0001127602-18-009370 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,934.9749 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:42 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Unit | 4,650 | $67.73 | $314,944.50 |
DisclosureSEC source: 0001127602-18-009704 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,370.5899 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:44 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
GrantStock Unit | 5,979 | $67.73 | $404,957.67 |
DisclosureSEC source: 0001127602-18-009707 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,911.2079 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:46 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Unit | 14,616 | $67.73 | $989,941.68 |
DisclosureSEC source: 0001127602-18-009711 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,408.8535 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:54 UTC |
Denton David MEVP and CFO
|
Tax withholdingCommon Stock | 1,613 | $67.73 | $109,248.49 |
DisclosureSEC source: 0001127602-18-009717 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,102.99 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:54 UTC |
Denton David MEVP and CFO
|
GrantCommon Stock | 5,315 | $67.73 | $359,984.95 |
DisclosureSEC source: 0001127602-18-009717 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,715.99 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:56 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 1,208 | $67.73 | $81,817.84 |
DisclosureSEC source: 0001127602-18-009718 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,846.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:56 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantCommon Stock | 3,986 | $67.73 | $269,971.78 |
DisclosureSEC source: 0001127602-18-009718 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,054.059 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:59 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
Tax withholdingCommon Stock | 885 | $67.73 | $59,941.05 |
DisclosureSEC source: 0001127602-18-009719 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,594 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:59 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
GrantCommon Stock | 2,923 | $67.73 | $197,974.79 |
DisclosureSEC source: 0001127602-18-009719 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,479 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 242 | $67.73 | $16,390.66 |
DisclosureSEC source: 0001127602-18-009722 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,489.9749 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
GrantCommon Stock | 797 | $67.73 | $53,980.81 |
DisclosureSEC source: 0001127602-18-009722 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,731.9749 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 16, 2018 22:05 UTC Amendment |
Denton David MEVP and CFO
|
OtherCommon Stock | 1,851 | $67.73 | $125,368.23 |
DisclosureSEC source: 0001127602-18-011887 · form4a.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,251.99 F1 · shares: Represents shares of stock issued under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, pursuant to the terms of the separation agreement. Though originally reported on a Form 4 to be owned by the reporting person, these shares are actually considered to be owned by the ex-spouse and are not beneficially owned by the reporting person. The shares remain subject to a two-year holding period. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:40 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 197 | $68.25 | $13,445.25 |
DisclosureSEC source: 0001127602-18-009370 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,276.9749 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC |
Denton David MEVP and CFO
|
OtherStock Option · Derivative | 10,869 | $0.00 Strike: $78.05 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,310 Underlying: Common Stock · 10,869 shares Expires 2024-04-03 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F7 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC |
Denton David MEVP and CFO
|
OtherStock Option · Derivative | 22,716 | $0.00 Strike: $104.82 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,980 Underlying: Common Stock · 22,716 shares Expires 2023-04-01 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F6 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC |
Denton David MEVP and CFO
|
OtherStock Option · Derivative | 25,540 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,382 Underlying: Common Stock · 25,540 shares Expires 2022-04-01 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC |
Denton David MEVP and CFO
|
OtherStock Option · Derivative | 30,325 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,618 Underlying: Common Stock · 30,325 shares Expires 2021-04-01 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC |
Denton David MEVP and CFO
|
OtherCommon Stock | 18,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400.99 F2 · shares: Represents shares that have been transferred to the reporting person's ex-spouse pursuant to a divorce decree on various dates during the 90-day waiting period under the decree that ended on or about February 20, 2018. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC |
Denton David MEVP and CFO
|
OtherCommon Stock (restricted) | 38,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,041 F1 · shares: Represents restricted stock units (RSUs) that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The RSUs held in trust for the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:11 UTC |
Foulkes HelenaEVP & President-CVS Pharmacy
|
Exercise / conversionStock Option · Derivative | 19,965 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-18-007529 · form4.xml · derivative · entry 3 Foulkes Helena · CIK 0001429996 · EVP & President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,965 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:11 UTC |
Foulkes HelenaEVP & President-CVS Pharmacy
|
SaleCommon Stock | 19,965 | $71.04 | $1,418,313.60 |
DisclosureSEC source: 0001127602-18-007529 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP & President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,107.3477 Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:11 UTC |
Foulkes HelenaEVP & President-CVS Pharmacy
|
Exercise / conversionCommon Stock | 19,965 | $45.07 | $899,822.55 |
DisclosureSEC source: 0001127602-18-007529 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP & President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,072.3477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:39 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
SaleCommon Stock | 29,445 | $75.00 | $2,208,375.00 |
DisclosureSEC source: 0001127602-17-035452 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,556 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:09 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 2,174.2281 | $68.99 Strike: $0.00 | $150,000.00 |
DisclosureSEC source: 0001127602-17-031724 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,261.9674 Underlying: Common Stock · 2,174.2281 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:12 UTC |
SWIFT RICHARD JDirector
|
GrantShare Credits · Derivative | 1,657.849 | $68.99 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-17-031730 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,420.0847 Underlying: Common Stock · 1,657.849 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:14 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 2,029.2796 | $68.99 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-031731 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,030.5487 Underlying: Common Stock · 2,029.2796 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:20 UTC |
Finucane Anne A.Director
|
GrantShare Credits · Derivative | 1,521.9597 | $68.99 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-17-031739 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,585.9988 Underlying: Common Stock · 1,521.9597 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. The share credits are scheduled to be settled in common stock in 2022. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:26 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 2,029.2796 | $68.99 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-031743 · form4.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,782.5271 Underlying: Common Stock · 2,029.2796 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. The share credits are scheduled to be settled in common stock in 2022. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:28 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 2,029.2796 | $68.99 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-031747 · form4.xml · derivative · entry 1 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,362.5194 Underlying: Common Stock · 2,029.2796 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:46 UTC |
BRACKEN RICHARD MDirector
|
GrantCommon Stock | 1,630 | $68.99 | $112,453.70 |
DisclosureSEC source: 0001127602-17-031759 · form4.xml · nonDerivative · entry 1 BRACKEN RICHARD M · CIK 0001216830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,263 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:48 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,521 | $68.99 | $104,933.79 |
DisclosureSEC source: 0001127602-17-031764 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,413 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:01 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,521 | $68.99 | $104,933.79 |
DisclosureSEC source: 0001127602-17-031769 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:59 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 4,131 | $68.99 | $284,997.69 |
DisclosureSEC source: 0001127602-17-031767 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,338 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:02 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,521 | $68.99 | $104,933.79 |
DisclosureSEC source: 0001127602-17-031771 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,520 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 08, 2017 Filed Feb 9, 2018 22:12 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
GiftCommon Stock | 222 | $68.99 | $15,315.78 |
DisclosureSEC source: 0001127602-18-004968 · form5.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,762.5252 Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:08 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 20,547 | $0.00 Strike: $48.67 | $0.00 |
DisclosureSEC source: 0001127602-17-028904 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,547 shares Expires 2022-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 10/1/2015. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:08 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 20,547 | $81.17 | $1,667,771.22 |
DisclosureSEC source: 0001127602-17-028904 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,630.9183 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $80.85 and $81.59 per share. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:08 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 20,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028904 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,177.9183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 20:42 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Exercise / conversionStock Option · Derivative | 85,743 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-027732 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85,743 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 20:42 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
SaleCommon Stock | 85,743 | $83.14 | $7,128,673.02 |
DisclosureSEC source: 0001127602-17-027732 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,812.1293 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $82.89 and $83.35 per share. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 20:42 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 85,743 | $34.96 | $2,997,575.28 |
DisclosureSEC source: 0001127602-17-027732 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,555.1293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 20:44 UTC |
Foulkes HelenaEVP & President-CVS Pharmacy
|
Exercise / conversionStock Option · Derivative | 39,340 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-17-027733 · form4.xml · derivative · entry 6 Foulkes Helena · CIK 0001429996 · EVP & President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,340 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 20:44 UTC |
Foulkes HelenaEVP & President-CVS Pharmacy
|
SaleCommon Stock | 39,340 | $81.88 | $3,221,159.20 |
DisclosureSEC source: 0001127602-17-027733 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP & President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,996.6533 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $81.51 and $82.11 per share. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 20:44 UTC |
Foulkes HelenaEVP & President-CVS Pharmacy
|
Exercise / conversionCommon Stock | 39,340 | $54.53 | $2,145,210.20 |
DisclosureSEC source: 0001127602-17-027733 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP & President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,336.6533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.